home / stock / bvnkf / bvnkf short
Short Information | Bavarian Nordic R/I Ord (OTCMKTS:BVNKF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,897 |
Total Actual Volume | 9,828 |
Short Trends | |
---|---|
Cover Days | 5 |
Short Days | 14 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 395 |
Average Short Percentage | 72.49% |
Is there a BVNKF Short Squeeze or Breakout about to happen?
See the BVNKF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-17-2024 | $0 | $21.2 | $0 | $0 | 1,003 | 1,000 | 99.7% |
05-10-2024 | $0 | $21.2 | $0 | $0 | 10 | 10 | 100% |
04-01-2024 | $22.6 | $22.6 | $22.6 | $22.6 | 106 | 100 | 94.34% |
02-23-2024 | $24.91 | $24.91 | $24.91 | $24.91 | 118 | 15 | 12.71% |
02-09-2024 | $22 | $21.8685 | $22.56 | $21.8685 | 700 | 100 | 14.29% |
01-29-2024 | $21.83 | $21.83 | $21.83 | $21.83 | 106 | 5 | 4.72% |
01-18-2024 | $0 | $24.73 | $0 | $0 | 1 | 1 | 100% |
12-28-2023 | $27 | $27 | $27 | $27 | 1,035 | 1,000 | 96.62% |
12-26-2023 | $26 | $26 | $26 | $26 | 1,000 | 1,000 | 100% |
12-01-2023 | $25.07 | $22.71 | $25.07 | $22.71 | 660 | 550 | 83.33% |
10-27-2023 | $18 | $18 | $18 | $18 | 1,000 | 1,000 | 100% |
10-23-2023 | $19.28 | $19.26 | $19.28 | $19.26 | 410 | 404 | 98.54% |
09-13-2023 | $20 | $21.31 | $21.31 | $20 | 950 | 950 | 100% |
08-04-2023 | $20.97 | $20.97 | $20.97 | $20.97 | 125 | 20 | 16% |
06-13-2023 | $31.95 | $32.05 | $32.05 | $31.95 | 503 | 100 | 19.88% |
06-12-2023 | $31.1 | $31.1 | $31.1 | $31.1 | 205 | 142 | 69.27% |
06-07-2023 | $30 | $30.16 | $30.16 | $30 | 1,075 | 1,000 | 93.02% |
05-16-2023 | $31.2 | $31.2 | $31.2 | $31.2 | 100 | 100 | 100% |
05-11-2023 | $29.85 | $30.43 | $30.55 | $29.85 | 620 | 300 | 48.39% |
05-10-2023 | $29.85 | $29.85 | $29.85 | $29.85 | 101 | 100 | 99.01% |
News, Short Squeeze, Breakout and More Instantly...
Bavarian Nordic R/I Ord Company Name:
BVNKF Stock Symbol:
OTCMKTS Market:
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for i...
COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS ® , the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant expansion for access to JYNNEOS ® by establishing additional pathwa...
Accelerated assessment allows for a shorter review period with EMA. Bavarian Nordic is on track to submit its Marketing Authorisation Application for CHIKV VLP to EMA during H1 2024. COPENHAGEN, Denmark, February 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) (“the Company...